Lucchesi, Daniela
Randazzo, Emioli
Del Prato, Stefano
Bianchi, Cristina http://orcid.org/0000-0003-2799-2380
Article History
Received: 30 March 2023
Accepted: 11 August 2023
First Online: 20 September 2023
Declarations
:
: Daniela Lucchesi and Emioli Randazzo report no duality of interest. Stefano Del Prato declares grants from AstraZeneca and Boehringer Ingelheim, consulting fees from Applied Therapeutics, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck Sharpe and Dohme, Novartis Pharmaceuticals, Novo Nordisk and Sanofi, and honoraria for lectures from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck Sharpe and Dohme, Novartis Pharmaceuticals, Novo Nordisk and Sanofi. Cristina Bianchi reports consulting fees and grants from Lilly, Novo Nordisk, MSD.
: The proband, who has given consent to the anonymous publication of the clinical report, was born in 1972 from eutocic childbirth, with a birth weight of 2750 g. Family history was positive for diabetes mellitus (father and paternal grandfather); none of them experienced chronic diabetes complications.
: The article describes a clinical report anonymously, in agreement with the patient who provided informed consent.